Skip to main content
Skip to secondary navigation
Stanford University
(link is external)
Search this site
Submit Search
Menu
Home
Team
Research
Publications
News
Resources
Get involved
News
Main content start
News
New strategy could turn IV medicines into pills
Jeffrey Glenn granted $14.3 million to develop broad spectrum drugs
The Innovative Medicines Accelerator turns its focus on COVID-19
ChEM-H researchers work toward new understanding of cancer camouflage
Antiviral treatments lead researchers to develop possible cancer drug
Zinc chelation may be able to deliver drug to insulin-producing cells
Researchers use zinc to target insulin-producing cells with regenerative drug
$28 million grant launches Center of Excellence for Translation Research
Back to Top
